These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6815409)

  • 41. A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites.
    Wood JN; Hudson L; Jessell TM; Yamamoto M
    Nature; 1982 Mar; 296(5852):34-8. PubMed ID: 6174868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycoinositol phospholipids from Trypanosoma cruzi transmit signals to the cells of the host immune system through both ceramide and glycan chains.
    DosReis GA; Peçanha LM; Bellio M; Previato JO; Mendonça-Previato L
    Microbes Infect; 2002 Jul; 4(9):1007-13. PubMed ID: 12106795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chagas' disease: a clinical, parasitological, immunological, and pathological study in rabbits.
    Teixeira AR; Figueiredo F; Rezende Filho J; Macêdo V
    Am J Trop Med Hyg; 1983 Mar; 32(2):258-72. PubMed ID: 6404186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The immunology of experimental Chagas' disease. I. Preparation of Trypanosoma cruzi antigens and humoral antibody response to there antigens.
    Teixeira AR; Santos-Buch CA
    J Immunol; 1974 Sep; 113(3):859-69. PubMed ID: 4213449
    [No Abstract]   [Full Text] [Related]  

  • 45. Variations in cell-mediated immunity to Trypanosoma cruzi during experimental Chagas' disease.
    Maleckar JR; Kierszenbaum F
    Ann Trop Med Parasitol; 1983 Jun; 77(3):247-54. PubMed ID: 6226246
    [No Abstract]   [Full Text] [Related]  

  • 46. Destruction of Trypanosoma cruzi by Natural killer cells.
    Hatcher FM; Kuhn RE
    Science; 1982 Oct; 218(4569):295-6. PubMed ID: 6812218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trypanosoma cruzi: infection of T lymphocytes and their destruction by antibody-dependent cell-mediated cytotoxicity.
    Velge P; Kusnierz JP; Ouaissi A; Marty B; Pham BN; Capron A
    Eur J Immunol; 1991 Sep; 21(9):2145-52. PubMed ID: 1909643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoimmunity in Chagas' disease: immunomodulation of autoimmune and T. cruzi-specific immune responses.
    Rizzo LV; Cunha-Neto E; Teixeira AR
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():360-2. PubMed ID: 3150998
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibody dependent cell-mediated cytotoxicity against Trypanosoma cruzi.
    Abrahamsohn IA; Silva WD
    Parasitology; 1977 Dec; 75(3):317-23. PubMed ID: 415286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunoprotection in rats by cultured epimastigotes of Trypanosoma cruzi].
    Rodríguez AM; Afchain D; Rivera-Vanderpas MT; Bazin H; Capron A
    Medicina (B Aires); 1983; 43(4):383-90. PubMed ID: 6419005
    [No Abstract]   [Full Text] [Related]  

  • 51. EVI antibodies in patients with Chagas' disease: relationship with anti-Trypanosoma cruzi immunoglobulins and effects of specific treatment.
    Brener Z; Ramirez LE; Krettli AU; Cançado JR
    Mem Inst Oswaldo Cruz; 1983; 78(4):437-42. PubMed ID: 6443630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione.
    Ouaissi A; Guevara-Espinoza A; Chabé F; Gomez-Corvera R; Taibi A
    Immunol Lett; 1995 Dec; 48(3):221-4. PubMed ID: 8867855
    [No Abstract]   [Full Text] [Related]  

  • 53. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
    Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
    Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the cellular immune response in Chagas' disease patients.
    Castes M; Araujo Z; Mosca W
    Acta Cient Venez; 1986; 37(5):547-53. PubMed ID: 3129894
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunoenzymatic assy (ELISA) in mucocutaneous leishmaniasis, kala-azar, and Chagas' disease: an epimastigote Trypanosoma cruzi antigen able to distinguish between anti-Trypanosoma and anti-Leishmania antibodies.
    Guimarães MC; Celeste BJ; de Castilho EA; Mineo JR; Diniz JM
    Am J Trop Med Hyg; 1981 Sep; 30(5):942-7. PubMed ID: 6792937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Circulating immune complexes in experimental Chagas' disease. Identification of parasitic antigens in the complexes].
    Chaves J; Ferri RG; Kliemann TA; Irulegui I; de Souza HB
    Rev Inst Med Trop Sao Paulo; 1979; 21(2):77-81. PubMed ID: 113861
    [No Abstract]   [Full Text] [Related]  

  • 57. Is there a link between the human TRIM21 and Trypanosoma cruzi Clone 36 genes in Chagas' disease?
    Winkler MA; Pan AA
    Mol Immunol; 2010; 48(1-3):365-7. PubMed ID: 20709399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma membrane origin on Trypanosoma cruzi antigenic determinants in Chagas' disease.
    Carniol C; Neves M; Zingales B; de Araujo PS; Colli W
    Rev Inst Med Trop Sao Paulo; 1982; 24(2):83-7. PubMed ID: 6182595
    [No Abstract]   [Full Text] [Related]  

  • 59. [Trypanosoma cruzi: activity of mouse immune sera on the tyrpomastigote stage].
    González Cappa SM; Katzin AM; Lajmanovich S
    Medicina (B Aires); 1979; 39(2):187-92. PubMed ID: 116105
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunology of Chagas' disease. III--Absorption of human chagasic sera with epimastigotes of different strains of Trypanosoma cruzi.
    Araujo FG; Nunes RM
    Rev Inst Med Trop Sao Paulo; 1978; 20(6):315-7. PubMed ID: 108797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.